A detailed history of Covestor LTD transactions in Care Dx, Inc. stock. As of the latest transaction made, Covestor LTD holds 5 shares of CDNA stock, worth $125. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 9 44.44%
Holding current value
$125
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$14.41 - $33.99 $57 - $135
-4 Reduced 44.44%
5 $0
Q4 2023

Feb 09, 2024

SELL
$4.9 - $12.86 $4 - $12
-1 Reduced 10.0%
9 $0
Q3 2023

Nov 13, 2023

SELL
$7.0 - $11.26 $14 - $22
-2 Reduced 16.67%
10 $0
Q2 2023

Aug 11, 2023

BUY
$7.61 - $9.46 $45 - $56
6 Added 100.0%
12 $0
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $32 - $52
-2 Reduced 25.0%
6 $0
Q2 2022

Aug 10, 2022

BUY
$20.49 - $39.72 $20 - $39
1 Added 14.29%
8 $0
Q1 2022

May 13, 2022

SELL
$28.19 - $46.6 $56 - $93
-2 Reduced 22.22%
7 $0
Q4 2021

Feb 10, 2022

BUY
$41.2 - $73.6 $370 - $662
9 New
9 $0

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.34B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.